Symbols / NTBL
NTBL Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-08-14 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $0.25 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-09-20 | down | JMP Securities | Market Outperform → Market Perform | — |
| 2024-05-16 | main | Chardan Capital | Buy → Buy | $5 |
| 2024-04-15 | reit | JMP Securities | Market Outperform → Market Outperform | $9 |
| 2024-04-15 | main | Chardan Capital | Buy → Buy | $7 |
- Notable Labs Closes Merger Transaction With VBL Therapeutics - Yahoo Finance Mon, 16 Oct 2023 07
- After a tough year, VBL merges with Notable Labs - Fierce Biotech hu, 23 Feb 2023 08
- Notable Labs files for bankruptcy, board resigns - Investing.com ue, 15 Oct 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NTBL
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|